Be Informed
A central source to connect Australians with high quality reliable medical, research and regulatory information on valproate and the dangers associated with it 's use.
The information is compiled by a qualified pharmaceutical scientist who has professional experience in pharmaceutical development, pharmaceutical business management and medication safety.
This is not an anti-medication website.
This initiative aims to ensure all Australians can access reliable information about sodium valproate. By raising awareness and understanding of this vital medication, we can prevent poor outcomes for current and future generations.
Australia's patient safety regulations and restrictions apply considerably less caution with those of countries it has strong ties with for medicine regulation, such as the UK, Canada, Singapore, and the European Union.
The website is primarily composed of links to external sources, which is intended to promote transparency. This allows all visitors to verify the validity of the information, draw their own conclusions about the sources and content, and pursue further research to make informed decisions.
Information Matters
"Bigger than Thalidomide"
Thalidomide stands as the most significant pharmaceutical scandal in history, impacting numerous nations, with Australia experiencing particular difficulties due to the slow removal of the drug from circulation. Originally prescribed for morning sickness, it resulted in severe birth defects in the babies of those mothers who used thalidomide. In 2023, the Australian government initiated a compensation program and allocated funds for supplementary healthcare requirements. The drug was withdrawn from the market in 1962, and it took more than six decades for the authorities to take action.
The Royal Pharmaceutical Society (professional organisation for pharmacists in the UK) has stated about valproate that "every baby is at risk and the scale of the issue, and the harm caused, is bigger than Thalidomide"